Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Heritage Bio Labs

Research Library

Explore 411 articles about peptides, research compounds and related topics, with links to the original studies.

Browse by productGeneral topics

Find articles

All articles

Showing 157–168 of 411 articles

  • Check methods and identity

    What a noninvasive liver score measured in the SAMARA trial

    Semaglutide is a modified peptide that activates the GLP-1 receptor. The SAMARA study, published in 2026, asked whether noninvasive tests could detect a change in adults with suspected at-risk metabolic dysfunction-associated steatohepatitis, or MASH, who were assigned to semaglutide or placebo.

    GLP-1 SEMA2 sources (2026)

  • Explore study findings

    What a 2026 analysis found across sleep apnea subgroups

    Tirzepatide is a modified peptide that activates the GIP and GLP-1 receptors. “GLP-2 TIRZ” is the catalog label. Tirzepatide’s tested targets are GIP and GLP-1, distinct from the GLP-2 receptor. A 2026 analysis asked how sleep apnea outcomes varied with participants’ starting characteristics.

    GLP-2 TIRZ3 sources (2022–2026)

  • Interpret the evidence

    Why the heart outcomes trial used an active comparator

    Tirzepatide activates GIP and GLP-1 receptors. The catalog wording “GLP-2 TIRZ” refers to tirzepatide and does not identify a GLP-2 target.

    GLP-2 TIRZ3 sources (2022–2026)

  • Check methods and identity

    What an antibody add-on study measured besides weight

    Tirzepatide is a peptide that activates GIP and GLP-1 receptors. The “GLP-2” wording in the catalog label does not correspond to a receptor target.

    GLP-2 TIRZ2 sources (2022, 2026)

  • Check methods and identity

    How SURMOUNT-MAINTAIN tested weight maintenance

    Tirzepatide activates GIP and GLP-1 receptors. In “GLP-2 TIRZ,” the GLP-2 wording is a catalog identifier. The SURMOUNT-MAINTAIN trial examined what happened to body weight after adults had already taken tirzepatide during an initial weight-loss phase.

    GLP-2 TIRZ2 sources (2022, 2026)

  • Explore study findings

    What a head-to-head trial taught researchers about glucose categories

    Tirzepatide is a peptide that activates GIP and GLP-1 receptors. It appears under “GLP-2 TIRZ” in the catalog, a name distinct from its receptor targets.

    GLP-2 TIRZ3 sources (2022–2026)

  • Understand the science

    Which two receptors recognize tirzepatide?

    Tirzepatide is designed to activate the receptors for glucose-dependent insulinotropic polypeptide, called GIP, and glucagon-like peptide-1, called GLP-1. The “GLP-2” part of the catalog label refers to the label alone.

    GLP-2 TIRZ1 source (2022)

  • Interpret the evidence

    What a 2026 blood study can tell us about glutathione exposure

    Glutathione is a naturally occurring three-amino-acid peptide that can shift between reduced and oxidized forms. A 2026 clinical study compared several glutathione products and asked how levels of the peptide and related compounds changed in blood.

    Glutathione2 sources (2014, 2026)

  • Check methods and identity

    What the October 2026 recall tells us about product quality

    Glutathione is a naturally occurring peptide made of three amino acids that participates in those protective reactions. A recall posted by the FDA in October 2026 concerned a different question, whether certain compounded glutathione products met a safety standard for bacterial endotoxins.

    Glutathione2 sources (2019, 2026)

  • Check methods and identity

    Why brain glutathione and blood flow were measured separately

    Glutathione is a three-amino-acid peptide produced by cells, including cells in the brain. In October 2026, researchers reported a human study in which they measured brain glutathione and blood flow during a dietary comparison.

    Glutathione1 source (2026)

  • Understand the science

    How baseline glutathione mattered in a human muscle study

    Glutathione is a naturally produced three-amino-acid peptide involved in that balance. A 2026 human study examined whether baseline glutathione status mattered for the response of muscle to an experimental injury.

    Glutathione1 source (2026)

  • Check methods and identity

    Why a glutathione acne trial measured both blood markers and skin changes

    Glutathione is a naturally occurring three-amino-acid peptide involved in those reactions. A small randomized acne trial published in September 2025, just before the recent research window, examined both blood markers and changes in acne severity.

    Glutathione1 source (2025)

Browse by product

General topics

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice. Library index (JSON)